Pharmaceutical & Biotech
Vetter Pharma Nears Completion of First U.S. Fill-and-Finish Plant
Germany's Vetter Pharma, which specializes in aseptically prefilled drug-delivery systems, is entering the final stretch of construction on a 25,000-square-foot...
Released Wednesday, September 15, 2010
Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Germany's Vetter Pharma, which specializes in aseptically prefilled drug-delivery systems, is entering the final stretch of construction on a 25,000-square-foot production facility at the Illinois Science +Technology Park in Skokie, Illinois.
Vetter launched its presence in the U.S. in 1983, with the opening of a marketing office in Yardley, Pennsylvania. Following the opening of a sales and marketing office last year at the Skokie site (replacing Yardley), the company soon will complete construction of its inaugural U.S. production plant.
Operating under "Vetter Pharma USA," the plant will offer clinical-scale fill-and-finish capacity on a contract basis. An estimated two-thirds of drug products in Phase I and Phase II clinical trials are in North America; as a result, reportedly half of Vetter's customers are based in North America. The Skokie site, which is just outside Chicago, offers access to a major airport, with direct rail service being added.
Production will be conducted in three clean-room areas. One will feature a semi-automated filling line for a variety of packaging forms, ranging from vials to dual-chamber syringes, and will be capable of filling 500 to 600 items per batch, for Phase I and Phase II clinical trials. Another clean room will house a Bosch filling system, which is new to the market, introduced only last year and prized for its precise control. The remaining clean room will feature a filling line dedicated to higher quantities of single-chamber syringes.
The Illinois Science + Technology Park was previously owned by Pfizer Incorporated (NYSE:PFE) (New York, New York) and is now owned by Forest City Enterprises (NYSE:FCE-A) (Cleveland, Ohio). Bulley & Andrews LLC (Chicago, Illinois), with its Meyne division, is handling construction of the $12 million project, which will include the addition of microbiology and quality control laboratories. Construction is expected by the end of the year.
View Plant Report - 1088909
View Project Report - 200003898
Industrial Info Resources (IIR) is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. IIR's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities.
/news/article.jsp
false
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Learn MoreIndustrial Project Opportunity Database and Project Leads
Get access to verified capital and maintenance project leads to power your growth.
Learn MoreIndustry Intel
-
2026 Regional Chemical Processing OutlookOn-Demand Podcast / Mar. 2, 2026
-
From Data to Decisions: How IIR Energy Helps Navigate Market VolatilityOn-Demand Podcast / Nov. 18, 2025
-
Navigating the Hydrogen Horizon: Trends in Blue and Green EnergyOn-Demand Podcast / Nov. 3, 2025
-
ESG Trends & Challenges in Latin AmericaOn-Demand Podcast / Nov. 3, 2025
-
2025 European Transportation & Biofuels Spending OutlookOn-Demand Podcast / Oct. 27, 2025